Bright Minds Biosciences Inc. (CSE:DRUG)

Bright Minds Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	51.39	5.72	6.75	11.63	19.76	0.8
Cash & Short-Term Investments	51.39	5.72	6.75	11.63	19.76	0.8
Cash Growth	730.14%	-15.23%	-41.97%	-41.15%	2370.22%	900.02%
Other Receivables	0.27	0.05	0.04	0.16	0.11	-
Receivables	0.27	0.05	0.04	0.16	0.11	-
Prepaid Expenses	0.71	0.22	0.03	0.16	0.17	0.08
Total Current Assets	52.37	5.99	6.81	11.95	20.04	0.88
Property, Plant & Equipment	0.13	0.12	0.07	0.14	-	-
Other Intangible Assets	-	-	-	-	0	0
Total Assets	52.5	6.1	6.88	12.09	20.04	0.88
Accounts Payable	0.51	0.41	0.18	1.25	0.6	0.14
Accrued Expenses	0.02	0.04	0.03	0.16	0.04	0.01
Current Portion of Leases	0.08	0.08	0.07	0.07	-	-
Total Current Liabilities	0.6	0.53	0.28	1.47	0.64	0.15
Long-Term Leases	0.06	0.04	-	0.07	-	-
Total Liabilities	0.67	0.57	0.28	1.54	0.64	0.15
Common Stock	89.91	35.42	33.91	32.24	27.08	0.98
Retained Earnings	-42.49	-34.35	-31.55	-24.17	-9.21	-0.56
Comprehensive Income & Other	4.41	4.46	4.23	2.48	1.53	0.31
Shareholders' Equity	51.83	5.54	6.6	10.54	19.4	0.73
Total Liabilities & Equity	52.5	6.1	6.88	12.09	20.04	0.88
Total Debt	0.14	0.12	0.07	0.14	-	-
Net Cash (Debt)	51.25	5.6	6.67	11.49	19.76	0.8
Net Cash Growth	729.74%	-16.08%	-41.90%	-41.86%	2370.22%	900.02%
Net Cash Per Share	8.28	1.30	1.79	4.65	11.01	1.11
Filing Date Shares Outstanding	7.08	6.99	4.46	3.74	2.37	1.27
Total Common Shares Outstanding	7.08	4.52	3.77	3.52	2.37	0.95
Working Capital	51.76	5.46	6.53	10.48	19.4	0.73
Book Value Per Share	7.32	1.22	1.75	3.00	8.20	0.77
Tangible Book Value	51.83	5.54	6.6	10.54	19.4	0.73
Tangible Book Value Per Share	7.32	1.22	1.75	3.00	8.20	0.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.